ICD-10-CM Billable Code

C81.04

Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb

Clinical Classification Guidelines

Medical Intelligence & Overview

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare type of Hodgkin lymphoma, a cancer that begins in the lymphatic system. Specifically classified under ICD-10 code C81.04, this subtype primarily involves the lymph nodes located in the axilla (armpit area) and upper limbs. Unlike classical Hodgkin lymphoma, NLPHL tends to grow slowly and has distinct cellular features. It often presents in adults but can affect individuals of any age. Early detection and appropriate treatment are vital for managing the disease effectively.

Causes & Symptoms

Clinical Causes: Genetic predispositions or inherited gene mutations Previous exposure to radiation or certain chemotherapies Weakened immune system due to infections or immunosuppressive therapies Environmental exposures to certain chemicals or toxins (though evidence is limited)

Key Symptoms: Swollen lymph nodes in the axilla (armpit) and upper limbs, usually painless Persistent fatigue or tiredness Unexplained weight loss Fever or chills without an apparent infection Night sweats Itching or skin rashes Discomfort or pain if lymph nodes press on nearby tissues

Diagnostic & Treatment

Diagnosis Path: Medical history review and physical examination focusing on enlarged lymph nodes Imaging tests such as ultrasound, CT scans, or PET scans to locate affected areas Lymph node biopsy to analyze tissue microscopically for characteristic Reed-Sternberg-like cells Immunohistochemistry testing to identify specific cellular markers, distinguishing NLPHL from other lymphomas Blood tests to assess overall health and organ function

Treatment Protocols: Radiation therapy aimed at the affected lymph nodes Chemotherapy regimens tailored to the patient's needs Immunotherapy approaches that target specific cancer cells Observation or 'watch and wait' in cases where the disease is slow-growing and asymptomatic Stem cell transplantation in advanced cases or relapses

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.04 a billable ICD-10 code?
Yes, C81.04 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.04?
Clinical documentation must specify the nature of Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

nodular axilla lymphocyte lymph nodes predominant hodgkin